Cited by 237Bone Metabolism and DiseasesProtease and Inhibitor MechanismsRheumatoid Arthritis Research and Therapies

Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-κB ligand.

Open access
Hikita, Atsuhiko, Yana, Ikuo, Wakeyama, Hidetoshi, Nakamura, Masaki, Kadono, Yuho, Oshima, Yasushi, Nakamura, Kozo, Seiki, Motoharu +1 more·2006·Journal of Biological Chemistry

Abstract

Receptor activator of NF-kappaB ligand (RANKL) is a transmembrane glycoprotein that has an essential role in the development of osteoclasts. The extracellular portion of RANKL is cleaved proteolytically to produce soluble RANKL, but definite RANKL sheddase(s) and the physiologic function of RANKL shedding have not yet been determined. In the present study, we found that matrix metalloproteinase (MMP) 14 and a disintegrin and metalloproteinase (ADAM) 10 have strong RANKL shedding activity. In Western blot analysis, soluble RANKL was detected as two different molecular weight products, and RNA interference of MMP14 and ADAM10 resulted in a reduction of both the lower and higher molecular weight products. Suppression of MMP14 in primary osteoblasts increased membrane-bound RANKL and promoted osteoclastogenesis in cocultures with macrophages. Soluble RANKL produced by osteoblasts from MMP14-deficient mice was markedly reduced, and their osteoclastogenic activity was promoted, consistent with the findings of increased osteoclastogenesis in vivo. RANKL shedding is an important process that down-regulates local osteoclastogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m606656200

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • RANKL has at least three forms, two of which possess a transmembrane domain and can be cleaved into soluble forms with osteoclast-stimulating activity.

    “There are at least three forms of RANKL, two of which possess a transmembrane domain that positions the biologically active carboxy-terminus to the extracellular domain (i.e., a type II transmembrane protein) (Fig. 2).One of these forms, RANKL2, is a shorter alternative splicing variant of RANKL1 (44).Both of these variants can remain on cell surfaces or can be proteolytically cleaved into soluble”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 41 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Hikita, A., Yana, I., Wakeyama, H., Nakamura, M., Kadono, Y., Oshima, Y., Nakamura, K., Seiki, M., & Tanaka, S.
Affiliations
  • The University of Tokyo (JP)
  • Institute of Medical Science, The University of Tokyo (JP)
Corresponding author
Tanaka, Sakae
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2006-12
Volume
281
Issue
48
Pages
36846-36855
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1999201913
Cited by
236
References
41
Citations by year
2026: 6 · 2025: 4 · 2024: 8 · 2023: 15 · 2022: 7 · 2021: 13 · 2020: 15 · 2019: 8 · 2018: 13 · 2017: 17 · 2016: 7 · 2015: 10 · 2014: 9 · 2013: 8 · 2012: 12
FWCI
6.66
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Keywords
RANKL, ectodomain shedding, osteoclastogenesis, MMP-14, ADAM10, soluble RANKL, osteoblasts
MeSH terms
ADAM10 Protein, Animals, Binding Sites, Bone Diseases, Metabolic, Bone Marrow, Humans, Macrophages, Membrane Proteins, Mice, Inbred C57BL, Osteoblasts, Osteoclasts, Down-Regulation, Coculture Techniques, Mice, ADAM Proteins, RANK Ligand, Matrix Metalloproteinase 14, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review